Expert makes case for patient-specific dosimetry

06/13/2013 | MolecularImaging.net

To improve patient diagnosis and therapy, there is a need to advance patient-specific dosimetry, said Hal Anger Lectureship & Award lecturer Michael G. Stabin, a researcher at Vanderbilt University School of Medicine, in a message at the SNMMI Annual Meeting. "We have a new generation of dose phantoms and selection of sophisticated [dose planning tools and] methods ... and it's time to incorporate dose calculations into clinical therapy planning ... Our understanding of radiobiology is undergoing profound change. We will be rewriting history soon," Stabin said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX